novo nordisk glp 1 pill With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins Rival GLP-1 pill matches Wegovy

I practice what I call integrative psychopharmacology

Novo Nordisk was filed on December 15, 2023

People with a personal or family history of medullary thyroid cancer or MEN-2 syndrome, those with a history of pancreatitis, pregnant or breastfeeding women, and several other groups need to avoid or carefully discuss these medicines

Concurrently, the development of oral GLP 1 receptor agonists is reshaping patient accessibility and adherence, addressing long-standing barriers associated with injectable therapies

While GLP-1 medications may cause headaches in some users, some early research is exploring whether GLP-1related mechanisms could influence certain headache conditions, particularly those living with obesity-related migraine or a condition called idiopathic intracranial hypertension (IIH) (which causes chronic headaches due to elevated pressure around the brain)

Everyone wins when information is easy to understand